GL1X · GenesisL1 explorer

MolNFT v1 · #160373 · protein

The evolving story of atzt, a periplasmic binding protein

6PII · Atrazine periplasmic binding protein: “The evolving story of atzt, a periplasmic binding protein”. X-ray diffraction, 4 ligands (GUN, EMC, CA), 17 pockets (best druggability 0.61). MolNFT v1 #160373 on GenesisL1: 3D structure…

PDB
6PII
Type
protein
Length
1,332 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Atrazine periplasmic binding protein
UniProt
Q936X6
Ligands
GUN, EMC, CA, PO4
Pockets
17 · best druggability 0.61

Structure

x-ray diffraction · 3 distinct chains · 40% helix, 23% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AAtrazine periplasmic binding proteinprotein33640% helix, 23% strandQ936X6
BAtrazine periplasmic binding proteinprotein33440% helix, 23% strandQ936X6
C, DAtrazine periplasmic binding proteinprotein33140% helix, 23% strandQ936X6

Ligands and binding sites

  • GUN · Guanine · ligand · 4 copies · chains A, B, C, D
  • EMC · Ethyl mercury ion · ligand · 4 copies · chains A, B, C, D
  • CA · Calcium ion · metal · chains C
  • PO4 · Phosphate ion · ion · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

17 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11700.610.8334empty
21920.580.8134empty
31290.540.8227empty
42650.530.7632empty
52260.500.7535empty

Interfaces

2 interfaces between chains.

  • B–D · 654 Ų buried · 11 hydrogen bonds · protein-protein
  • A–C · 640 Ų buried · 11 hydrogen bonds · protein-protein

Compared structures

  • 6PII · The evolving story of AtzT, a periplasmic binding protein · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.